BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22549898)

  • 1. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
    Shih WL; Yu FL; Chang CD; Liao MH; Wu HY; Lin PY
    Mol Carcinog; 2013 Oct; 52(10):800-12. PubMed ID: 22549898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-beta-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase.
    Shih WL; Liao MH; Lin PY; Chang CI; Cheng HL; Yu FL; Lee JW
    Cancer Lett; 2010 Apr; 290(2):223-37. PubMed ID: 19819066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of hepatitis B virus x protein-mediated tumorigenic effects by ursolic Acid.
    Wu HY; Chang CI; Lin BW; Yu FL; Lin PY; Hsu JL; Yen CH; Liao MH; Shih WL
    J Agric Food Chem; 2011 Mar; 59(5):1713-22. PubMed ID: 21314126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration.
    Shih WL; Liao MH; Yu FL; Lin PY; Hsu HY; Chiu SJ
    Cancer Lett; 2008 Nov; 270(2):202-17. PubMed ID: 18571835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
    Yu FL; Liao MH; Lee JW; Shih WL
    Biochem Biophys Res Commun; 2004 Jan; 314(1):76-82. PubMed ID: 14715248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
    Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP.
    Shyu MH; Kao TC; Yen GC
    J Agric Food Chem; 2010 May; 58(10):6110-8. PubMed ID: 20415421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor.
    Yang L; Liu X; Lu Z; Yuet-Wa Chan J; Zhou L; Fung KP; Wu P; Wu S
    Cancer Lett; 2010 Dec; 298(1):128-38. PubMed ID: 20630652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
    Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
    Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma.
    Liu T; Ma H; Shi W; Duan J; Wang Y; Zhang C; Li C; Lin J; Li S; Lv J; Lin L
    Int J Oncol; 2017 Aug; 51(2):555-562. PubMed ID: 28714512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells.
    Shi MD; Liao YC; Shih YW; Tsai LY
    Phytomedicine; 2013 Jun; 20(8-9):743-52. PubMed ID: 23537747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
    Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
    Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways.
    Song Y; Dai F; Zhai D; Dong Y; Zhang J; Lu B; Luo J; Liu M; Yi Z
    Angiogenesis; 2012 Sep; 15(3):421-32. PubMed ID: 22669534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma.
    Chan SL; Wong CH; Lau CP; Zhou Q; Hui CW; Lui VW; Ma BB; Chan AT; Yeo W
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1417-25. PubMed ID: 23546591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines.
    Yan SL; Huang CY; Wu ST; Yin MC
    Toxicol In Vitro; 2010 Apr; 24(3):842-8. PubMed ID: 20005942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway.
    Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F
    Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
    Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
    Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells.
    Ninomiya S; Shimizu M; Imai K; Takai K; Shiraki M; Hara T; Tsurumi H; Ishizaki S; Moriwaki H
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2092-100. PubMed ID: 21952585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.